2005
DOI: 10.1016/j.autneu.2005.07.005
|View full text |Cite
|
Sign up to set email alerts
|

Altered muscarinic receptor subtype expression and functional responses in cyclophosphamide induced cystitis in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

15
114
2
1

Year Published

2006
2006
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 86 publications
(133 citation statements)
references
References 26 publications
15
114
2
1
Order By: Relevance
“…In the current study, there was a marked decrease in the density of muscarinic and P2X receptors in the bladders of CYPtreated rats, as shown by a significant reduction in the B max for specific binding of [ 3 H]NMS and [ 3 H]abMeATP. These results revealed a down-regulation in pharmacologically relevant muscarinic and purinergic receptors in the bladders of rats with cystitis, which is consistent with pharmacological subsensitivity to cholinergic and purinergic agonists in CYP-treated bladders (22,23). The down-regulation of pharmacological receptors in CYP-treated bladders may reflect a compensatory mechanism, possibly due to the increased stimulation of receptors by acetylcholine or ATP (23 -26).…”
Section: Discussionsupporting
confidence: 61%
“…In the current study, there was a marked decrease in the density of muscarinic and P2X receptors in the bladders of CYPtreated rats, as shown by a significant reduction in the B max for specific binding of [ 3 H]NMS and [ 3 H]abMeATP. These results revealed a down-regulation in pharmacologically relevant muscarinic and purinergic receptors in the bladders of rats with cystitis, which is consistent with pharmacological subsensitivity to cholinergic and purinergic agonists in CYP-treated bladders (22,23). The down-regulation of pharmacological receptors in CYP-treated bladders may reflect a compensatory mechanism, possibly due to the increased stimulation of receptors by acetylcholine or ATP (23 -26).…”
Section: Discussionsupporting
confidence: 61%
“…Buffington et al [11] showed that acetylcholine release was not altered following EFS in bladder tissue strips of cats with feline interstitial cystitis. Giglio et al [12] further demonstrated that in cyclophosphamide-treated rats the expression and distribution of M2 and M3 receptor subtypes in the urothelium and smooth muscle layer were not changed when compared with control animals. However, they found that contractile responses to carbachol were significantly reduced in cyclophosphamide-treated tissues, possibly due to harmful effects of cyclophosphamide on smooth muscle contractility.…”
Section: Discussionmentioning
confidence: 96%
“…23 Bradykinin receptor B 1 and cannabinoid receptors CB1 and CB2 are involved in the regulation of pain and inflammatory responses in human bladder. 59,60 We detected a significant (P Ͻ 0.05) up-regulation of the inflammation-induced bradykinin receptor B 1 and cannabinoid CB1 receptors.…”
Section: Discussionmentioning
confidence: 99%
“…20 Such changes are indicative of the pathophysiological processes taking place during the progression of a disease; therefore some of the causative factors of BPS/IC might be elucidated by uncovering a link between the expression of proteins, mediating neurogenic inflammation, bladder contractility and epithelial permeability. Although there are several studies examining gene expression changes during experimentally induced cystitis in animals, [21][22][23][24][25] human data are scarce. In human BPS patients, the molecular markers for bladder permeability and proteoglycan core proteins have been shown to be down-regulated, 26,27 and there was an increased permeability and decreased tight junction formation of bladder epithelial cell monolayers grown from biopsies in patients with BPS/IC, as compared with cells from normal controls.…”
mentioning
confidence: 99%